BiomEdit Develops Poultry Antibody, Lands $20M In Funding
BiomEdit, a pioneering animal health biotechnology company, announced a significant milestone in the development of BE-101, its lead candidate for the prevention of mortality associated with necrotic enteritis in broiler chickens.
Read More